What would it take for Australia to manufacture mRNA vaccines? Experts say investing in RNA technology now will help to protect Australia, and its neighbours, beyond the current pandemic.
Anaphylaxis found to affect 0.025% of COVID-19 mRNA vaccine recipients New research utilising real-world data suggests the rate is largely comparable to most antibiotics.
Four things about mRNA vaccines researchers still want to find out At the top of the list is discovering a way to make them more stable at higher temperatures.
Australian coronavirus vaccine rollout to have a significant advantage Other countries are expected to begin administering doses within weeks, which experts say should provide certainty over any lingering doubts surrounding previously unused mRNA candidates.
‘We’re talking about a vaccine that has never been distributed in humans’ News of Pfizer/BioNTech’s COVID vaccine efficacy is ‘exciting’, but multiple Australian experts have told newsGP challenges lay ahead.
What if Australia can’t make mRNA COVID vaccines locally? The country could miss out on several options.